Does eating well above the protein RDA preserve muscle and is it unambiguously good for healthy aging?
Claim attributed to Peter Attia and the fitness/longevity community, in tension with Valter Longo's protein-restriction position , No verbatim quote was verified; this is a fair paraphrase of the muscle-centric "high protein optimizes longevity" camp, set against Longo's restriction position. Treat as representative, not a quote.
For older adults, exceeding the RDA to preserve muscle is solid, guideline-backed advice. But "unambiguously good for healthy aging" overreaches: in midlife the longevity signal is contested and may point the other way, and the optimum depends on age and protein source.
Great for keeping muscle as you age; "unambiguously good for longevity" is a claim no human trial has ever tested, and in midlife the data hint the other way.
What it’s supposed to target
- Muscle protein synthesis
- mTOR + IGF-1 growth signaling
- Sarcopenia / frailty
- Anabolic resistance (aging)
Protein is genuinely double-edged in aging biology, which is why this is a real debate, not a myth. On one side, dietary protein drives muscle protein synthesis through the mTOR pathway, and older muscle becomes anabolically resistant, so the argument is that eating well above the minimum RDA, plus resistance training, is needed to fight sarcopenia and frailty. On the other side, that same mTOR and IGF-1 growth signaling, helpful for muscle, is exactly what longevity research in animals links to faster aging and cancer, where protein restriction extends lifespan.
Both halves are partly right, which the slogans miss. For older adults, the muscle-and-function case is well supported: more protein with training preserves strength and independence, a clear healthspan win, and feared kidney harm in healthy people has not materialized. The contested half is the jump to “high protein optimizes longevity for everyone”: the growth-signaling concern rests largely on animal and midlife-cohort data, and the right dose probably depends on age, source, and context (a young athlete is not a 75-year-old). Excellent for keeping muscle, unsettled as a universal longevity rule.
Mechanism is theory, not proof. A plausible pathway explains why something might work, not whether it does. The verdict rests on the evidence below, not the elegance of the theory.
What would have to be true
Higher protein must preserve lean mass in older adults: HOLDS, via guidelines and the anabolic-resistance mechanism.
The benefit must extend to long-term survival and disease at all ages: DOES NOT HOLD; the midlife signal is contested and age-dependent.
Protein source must not change the effect: DOES NOT HOLD; animal protein drives the harm signal, plant protein attenuates it.
What the evidence actually shows
For older adults, the muscle case is real and endorsed
Older muscle shows anabolic resistance: it responds less to a given dose of protein, so the 0.8 g/kg/day RDA (a deficiency-prevention minimum, not an optimum) is likely too low with age. The PROT-AGE group recommends 1.0-1.2 g/kg/day for healthy older adults (1.2-1.5 if ill or sarcopenic), and ESPEN's geriatric guideline recommends at least 1.0 g/kg/day, both paired with resistance exercise. This is consensus-grade support for the narrow claim that more protein than the RDA helps older adults keep muscle and counter frailty.
"Unambiguously good" collides with the midlife data
In NHANES III (N=6,381, ~18-yr follow-up), Levine 2014 found adults aged 50-65 with high protein had ~75% higher all-cause mortality and a roughly fourfold higher cancer mortality (HR 4.33, 95% CI 1.96-9.56), an effect driven by animal protein and attenuated by plant protein. Crucially the pattern reversed after 66, where higher protein tracked with lower mortality. Independent experts called the cohort "too small to provide any robust conclusions" and poorly adjusted for smoking, weight, and socioeconomic status, so neither the harm nor the benefit extreme is firmly established.
Studies, graded, and who paid
Two expert bodies (PROT-AGE, ESPEN) recommend at least 1.0-1.2 g/kg/day plus resistance exercise; guideline-grade, not long-outcome RCTs.
Meta-analysis of 28 RCTs found no GFR effect in normal kidneys; fear largely unfounded, but trials short and industry-funded.
Observational and animal data link high animal protein to higher midlife cancer/mortality; the effect reverses after 66.
| # | Study | Type | Size | Funding / COI | Key limitations |
|---|---|---|---|---|---|
| 1 | Bauer 2013 PROT-AGE position paper | Expert consensus guideline | N/A (expert review) | Funding unknown EUGMS-appointed group; individual author industry ties common in this field but not extracted. | Extrapolates from mechanistic and short-term functional data; no long-outcome RCTs at these intakes. |
| 2 | Volkert 2019 ESPEN geriatric guideline | Clinical practice guideline | N/A (guideline) | Independent ESPEN professional-society process. | At-least-1.0 g/kg/day figure lives in full-text recommendations, not the abstract; consensus, not trial outcome. |
| 3 | Levine 2014 (NHANES III + mice) | Observational cohort + animal | 6,381 adults; plus mouse cohorts | Independent Academic/USC-Longo, NIH/foundation; Longo has commercial ties to ProLon/L-Nutra aligned with a restriction message. | Single 24-hour recall; animal protein confounded by red/processed meat and lifestyle; also showed ~5x diabetes-mortality rise at all ages. |
| 4 | Devries 2018 kidney meta-analysis | Meta-analysis of RCTs | 28 RCTs, 1,358 participants | Industry-funded Senior author Phillips disclosed dairy- and beef-industry funding; favorable conclusion warrants scrutiny though consistent with literature. | Short trials; applies only to normal kidney function, not chronic kidney disease. |
| 5 | Science Media Centre expert reaction | Independent expert commentary | N/A | Independent Collates independent academic commentary. | Commentary, not new data; critiques the strength of the Levine harm signal. |
The same dataset shows the protein-mortality relationship flips with age and tracks protein source, which undercuts any blanket 'always good' or 'always bad' framing.
Unproven ≠ disproven
The midlife cancer/mortality harm is a hypothesis from one modest observational cohort plus mouse data, not a tested-and-confirmed human effect; it is unproven, not established.
Where claim and evidence diverge
No long-term RCT randomizes healthy midlife adults to high versus moderate protein and tracks cancer and death over decades, so the longevity question rests on confounded cohorts and animal models.
The money trail
The muscle-benefit side is heavily industry-funded: the kidney meta-analysis discloses dairy and beef funding (National Dairy Council, Dairy Farmers of Canada, beef-cattlemen body), and supplement makers profit from 'eat more protein.' The restriction side has its own tilt via Longo's ProLon/L-Nutra. No sponsor is paid to fund a trial that might show protein harm.
The honest read
'More protein than the RDA helps older adults keep muscle and function' is well supported and worth acting on with resistance exercise. 'High protein is unambiguously good for healthy aging at every age' overreaches the evidence.
What would change this verdict
A long-term RCT in healthy midlife adults showing higher protein does not raise cancer or all-cause mortality.
A large pooled cohort confirming the after-66 survival benefit holds independent of overall diet quality and confounders.
Sources
- Bauer J, et al. PROT-AGE Study Group: optimal dietary protein intake in older people. J Am Med Dir Assoc. 2013;14(8):542-559. (PMID 23867520)
- Volkert D, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38(1):10-47. (PMID 30005900)
- Levine ME, et al. Low protein intake is associated with major reductions in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19(3):407-417.
- Devries MC, et al. Changes in kidney function do not differ between healthy adults consuming higher- vs lower- or normal-protein diets. J Nutr. 2018;148(11):1760-1775.
- Science Media Centre. Expert reaction to two new studies on dietary protein, health and longevity. 4 March 2014.
- ecancer news. Low protein intake in middle age is associated with lowered cancer risk. 2014 (reporting Levine et al.).
People also ask
- How much protein should older adults eat to preserve muscle?
- Expert bodies PROT-AGE and ESPEN recommend older adults eat at least 1.0 to 1.2 g/kg/day, well above the 0.8 g/kg RDA, paired with resistance exercise. This guidance is guideline-grade rather than from long-term outcome trials, but the muscle-preservation case is solid.
- Does high protein damage your kidneys?
- Not in people with healthy kidneys. A meta-analysis of 28 randomized trials found no effect on glomerular filtration rate in normal kidneys, so the fear is largely unfounded. The caveat: those trials were short and partly industry-funded.
- Is a high-protein diet good for longevity at every age?
- No, that overreaches. Observational and animal data link high animal protein to higher cancer and mortality risk in midlife, and the effect appears to reverse only after age 66. No long-term human trial has tested protein intake against lifespan.
- Is high animal protein worse than plant protein for aging?
- The longevity signal is specifically tied to high animal protein, which observational and animal data associate with higher midlife cancer and mortality. The optimum depends on both age and protein source, so source appears to matter, not just total amount.
Part of our guide: Longevity diets, fact-checked
Caveat is journalism, not medical advice. We check public claims against published evidence; we don’t diagnose, treat, or tell you what to take.